Stem Cell Therapeutic and Research Reauthorization Act of 2026
Stem Cell and Bone Marrow Transplant Programs: Funding Extension
This bill is currently in the early stages of the legislative process after being introduced in the Senate. It has been sent to the Committee on Health, Education, Labor, and Pensions for review and is considered active. No further actions or hearings have been scheduled at this time.
Part of: story →Legislative Progress
Key Points
- This bill continues a national program that helps patients find life-saving bone marrow and cord blood transplants. These treatments are often the last hope for people fighting blood cancers like leukemia or other rare diseases.
- It sets aside $33 million each year from 2027 through 2031 for the C.W. Bill Young Cell Transplantation Program. This money pays for the system that matches sick patients with volunteer donors from across the country.
- The plan also keeps the national cord blood inventory running for another five years. Cord blood is collected from umbilical cords after birth and contains special cells that can be used to treat patients who cannot find a matching bone marrow donor.
- By extending these programs, the government helps ensure that more people have access to a diverse pool of donors. This is especially important for patients from minority backgrounds who often have a harder time finding a perfect genetic match.
Impact Analysis
Govbase has not yet run an impact analysis on this legislation.
Milestones
Read twice and referred to the Committee on Health, Education, Labor, and Pensions. (Sponsor introductory remarks on measure: CR S1093)
Sent to a congressional committee for expert review. The committee decides whether this bill moves forward.
Introduced in Senate
The bill was officially filed and given a number. It now enters the legislative queue.
Votes
No votes have been recorded for this legislation yet.
News
No related news coverage found for this legislation yet.
Source Information
Document Type
Congressional Bill
Official Title
Stem Cell Therapeutic and Research Reauthorization Act of 2026
Data Sources
Sponsor
Cosponsors
(3)Analysis generated by AI. Always verify with official sources.